BACKGROUND: The high morbidity and mortality in African Americans associated with behavior-linked chronic diseases are well documented. METHODS: We tested the efficacy of an intervention to increase multiple health-related behaviors in African Americans. In a multisite cluster-randomized controlled trial, groups of African American human immunodeficiency virus (HIV)-serodiscordant heterosexual couples in Atlanta (Georgia), Los Angeles (California), New York (New York), and Philadelphia (Pennsylvania) were allocated to an individual-focused health promotion that addressed multiple health-related behaviors or to a couple-focused HIV/sexually transmitted disease (STD) risk reduction intervention. Primary outcomes were adherence to fruit and vegetable consumption and physical activity guidelines assessed preintervention, immediately postintervention, and 6 and 12 months postintervention. Secondary outcomes included fatty food consumption, prostate and breast cancer screening, and alcohol use. Generalized estimating equations tested the efficacy of the health promotion intervention over the postintervention assessments. RESULTS:Health promotion intervention participants were more likely to report consuming 5 or more servings of fruits and vegetables daily (rate ratio [RR], 1.38; 95% confidence interval [CI], 1.18 to 1.62) and adhering to physical activity guidelines (1.39; 1.22 to 1.59) compared with HIV/STD intervention participants. In the health promotion intervention compared with the HIV/STD intervention, participants consumed fatty foods less frequently (mean difference, -0.18; 95% CI, -0.30 to -0.07), more men received prostate cancer screening (RR, 1.51; 95% CI, 1.21 to 1.88), and more women received a mammogram (RR, 1.26; 95% CI, 1.06 to 1.50). Alcohol use did not differ between the intervention groups. CONCLUSION: This trial demonstrates the efficacy of interventions targeting multiple health-related behaviors in African American HIV-seropositive and HIV-seronegative men and women. Trial Registration clinicaltrials.gov Identifier: NCT00644163.
RCT Entities:
BACKGROUND: The high morbidity and mortality in African Americans associated with behavior-linked chronic diseases are well documented. METHODS: We tested the efficacy of an intervention to increase multiple health-related behaviors in African Americans. In a multisite cluster-randomized controlled trial, groups of African American human immunodeficiency virus (HIV)-serodiscordant heterosexual couples in Atlanta (Georgia), Los Angeles (California), New York (New York), and Philadelphia (Pennsylvania) were allocated to an individual-focused health promotion that addressed multiple health-related behaviors or to a couple-focused HIV/sexually transmitted disease (STD) risk reduction intervention. Primary outcomes were adherence to fruit and vegetable consumption and physical activity guidelines assessed preintervention, immediately postintervention, and 6 and 12 months postintervention. Secondary outcomes included fatty food consumption, prostate and breast cancer screening, and alcohol use. Generalized estimating equations tested the efficacy of the health promotion intervention over the postintervention assessments. RESULTS: Health promotion intervention participants were more likely to report consuming 5 or more servings of fruits and vegetables daily (rate ratio [RR], 1.38; 95% confidence interval [CI], 1.18 to 1.62) and adhering to physical activity guidelines (1.39; 1.22 to 1.59) compared with HIV/STD intervention participants. In the health promotion intervention compared with the HIV/STD intervention, participants consumed fatty foods less frequently (mean difference, -0.18; 95% CI, -0.30 to -0.07), more men received prostate cancer screening (RR, 1.51; 95% CI, 1.21 to 1.88), and more women received a mammogram (RR, 1.26; 95% CI, 1.06 to 1.50). Alcohol use did not differ between the intervention groups. CONCLUSION: This trial demonstrates the efficacy of interventions targeting multiple health-related behaviors in African American HIV-seropositive and HIV-seronegative men and women. Trial Registration clinicaltrials.gov Identifier: NCT00644163.
Authors: M K Campbell; W Demark-Wahnefried; M Symons; W D Kalsbeek; J Dodds; A Cowan; B Jackson; B Motsinger; K Hoben; J Lashley; S Demissie; J W McClelland Journal: Am J Public Health Date: 1999-09 Impact factor: 9.308
Authors: Nabila El-Bassel; John B Jemmott; J Richard Landis; Willo Pequegnat; Gina M Wingood; Gail E Wyatt; Scarlett L Bellamy Journal: Arch Intern Med Date: 2010-07-12
Authors: Valerianna Amorosa; Marie Synnestvedt; Robert Gross; Harvey Friedman; Rob Roy MacGregor; Debie Gudonis; Ian Frank; Pablo Tebas Journal: J Acquir Immune Defic Syndr Date: 2005-08-15 Impact factor: 3.731
Authors: Todd T Brown; Stephen R Cole; Xiuhong Li; Lawrence A Kingsley; Frank J Palella; Sharon A Riddler; Barbara R Visscher; Joseph B Margolick; Adrian S Dobs Journal: Arch Intern Med Date: 2005-05-23
Authors: Jeffrey A Meyerhardt; Edward L Giovannucci; Shuji Ogino; Gregory J Kirkner; Andrew T Chan; Walter Willett; Charles S Fuchs Journal: Arch Intern Med Date: 2009-12-14
Authors: Shiriki K Kumanyika; Thomas A Wadden; Justine Shults; Jennifer E Fassbender; Stacey D Brown; Marjorie A Bowman; Vivian Brake; William West; Johnetta Frazier; Melicia C Whitt-Glover; Michael J Kallan; Emily Desnouee; Xiaoying Wu Journal: Arch Intern Med Date: 2009-10-26
Authors: John B Jemmott; Alisa Stephens-Shields; Ann O'Leary; Loretta Sweet Jemmott; Anne Teitelman; Zolani Ngwane; Xoliswa Mtose Journal: Prev Med Date: 2015-01-04 Impact factor: 4.018
Authors: G Anita Heeren; John B Jemmott; C Show Marange; Arnold Rumosa Gwaze; Jesca Mercy Batidzirai; Zolani Ngwane; Andrew Mandeya; Joanne C Tyler Journal: Behav Med Date: 2017-08-04 Impact factor: 3.104
Authors: Jingwen Zhang; John B Jemmott; Ann O'Leary; Robin Stevens; Loretta Sweet Jemmott; Larry D Icard; Janet Hsu; Scott E Rutledge Journal: Ann Behav Med Date: 2017-02
Authors: John B Jemmott; Loretta S Jemmott; Zolani Ngwane; Jingwen Zhang; G Anita Heeren; Larry D Icard; Ann O'Leary; Xoliswa Mtose; Anne Teitelman; Craig Carty Journal: Prev Med Date: 2014-04-13 Impact factor: 4.018
Authors: John B Jemmott; Jingwen Zhang; Loretta S Jemmott; Larry D Icard; Zolani Ngwane; Monde Makiwane; Ann O'Leary Journal: J Adolesc Health Date: 2019-04-23 Impact factor: 7.830